Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

FDA is taking on tampons and ‘misleading’ ads starring Serena Williams

Good morning! I’ve decided today is the day that I must tell you about my favorite Instagram account: poeticpuppets. It’s an account (run by a

September 12, 2024

David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells

David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells

September 18, 2023

USDA releases H5N1 bird flu genetic data eagerly awaited by scientists

The U.S. Department of Agriculture, which has been under pressure from scientists both at home and abroad to share more data on the H5N1 bird

April 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.